Bayer's leadership has implemented aggressive restructuring measures, eliminating 70% of its managerial positions as part of a broader organizational transformation strategy. This significant workforce reduction represents the initial phase of the company's overhaul, with executives now facing the challenge of maintaining operational efficiency and employee morale during the transition. The deeper challenge lies ahead as the pharmaceutical giant must balance cost reduction with innovation and competitiveness in an increasingly demanding market landscape.

Summary auto-generated by AI from the original publisher's content. Editorial standards.